Selzer A.Atrial fibrillation revisited. N Engl J Med306:1044, 1982
2.
Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation98:946, 1998
3.
Benjamin EJ, Levy D., Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA271:840, 1994
4.
Lie JT, Falk RHPathology of atrial fibrillation: Insights from autopsy studies. In Falk RH, Podrid PJ (eds). Atrial Fibrillation: Mechanisms and Management. New York, NY, Raven, p 1, 1992
5.
Åberg H.Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand185:373, 1969
6.
Levy S.Epidemiology and classification of atrial fibrillation. J Cardiovasc Electrophysiol9:S78, 1998
7.
Brand FN, Abbott RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA254:3449, 1985
8.
Wolf PA, Abbott RD, Kannel WBAtrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke22:983, 1991
9.
Packer DL, Bardy GH, Worley SJ, et al. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction. Am J Cardiol57:563, 1986
10.
Moe GK, Rheinboldt WC, Abildskov JAA computer model of atrial fibrillation. Am Heart J67:200, 1964
11.
Elvan A., Ramanna H., Robles de Medina EONew insights into the pathophysiology and treatment of atrial fibrillation . ACC Current J Review8:11, 1999
12.
Skanes AC, Mandapati R., Berenfeld O., et al. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation98:1236, 1998
13.
Alessie MAReentrant mechanisms underlying atrial fibrillation. In Zipes DP, Jalife J (eds). Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA, W.B. Saunders, p 562, 1995
14.
Wijffels MC , Kirchhof CJ, Dorland R., et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation92:1954, 1995
15.
Haissaguerre M., Jais P., Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med339:659, 1998
16.
Zabalogitia M., Halperin JL, Pearce LA, et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation . J Am Coll Cardiol31:1622, 1998
17.
Laupacis A. , Albers G., Dunn M., et al. Antithrombotic therapy in atrial fibrillation . Chest102:426S, 1992
18.
Black IW, Fatkin D., Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: A multicenter study. Circulation89:2509, 1994
19.
Jung F., DiMarco JPTreatment strategies for atrial fibrillation. Am J Med104:272, 1998
20.
Kowey PR, VanderLugt JT, Luderer JRSafety and risk/ benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter. Am J Cardiol78:46, 1996
21.
Capucci A., Boriani G., Botto GL, et al. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol74:503, 1994
22.
Oral H., Souza JJ, Michaud GF, et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med340:1849, 1999
23.
Bjerregaard P., El-Shafei A., Janosik DL, et al. Double external direct-current shocks for refractory atrial fibrillation. Am J Cardiol83:972, 1999
24.
Levy S., Lauribe P., Dolla E., et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation86:1415, 1992
25.
Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med337:1785, 1997
26.
Gomes JA, Ip J., Santoni-Rugiu F., et al. Oral d,1 sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol34:334, 1999
27.
Kay GN, Ellenbogen KA, Guidici M., et al. The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. J Interventional Cardiac Electrophysiol2:121, 1998
28.
Chen SA, Lee SH, Chiang CE, et al. Electrophysiological mechanisms in successful radiofrequency catheter modification of atrioventricular junction for patients with medically refractory paroxysmal atrial fibrillation. Circulation93:1690, 1996
29.
Costeas C., Kassotis J., Blitzer M., et al. Rhythm management in atrial fibrillation—with a primary emphasis on pharmacological therapy: Part 2. Pacing Clin Electrophysiol21:742, 1998
30.
Steinbeck G. , Remp T., Hoffmann E.Effects of Class I drugs on atrial fibrillation . J Cardiovasc Electrophysiol9:S104, 1998
31.
Cappucci A. , Villani GQ, Aschieri D., et al. Effects of Class III drugs on atrial fibrillation. J Cardiovasc Electrophysiol9:S109, 1998
32.
Anderson JLSotalol, bretylium and other class III antiarrhythmic agents. In Podrid PJ, Kowey PR (eds). Cardiac Arrhythmia. Mechanism, Diagnosis and Management. Baltimore, MD, Williams and Wilkins, p 450, 1995
33.
Gosselink AT , Crijns HJ, Van Gelder IC, et al. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA24:3289, 1992
34.
Torp-Pedersen C., Moller M., Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med341:857, 1999
35.
Page RL, Connolly SJ, Marcello SR, et al. Dose response for azimilide treatment of paroxysmal supraventricular tachycardia. Pacing Clin Electrophysiol22:770, 1999
36.
Albers GW, Atwood JE, Hirsh J., et al. Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med115:727, 1991
37.
TheStroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med116:1, 1992
38.
Morley J., Marinchak R., Rials SJ, et al. Atrial fibrillation, anticoagulation, and stroke. Am J Cardiol77:38A, 1996
39.
TheSPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA279:1273, 1998
40.
Atrial Fibrillation Investigators.The efficacy of aspirin in patients with atrial fibrillation: Analysis of pooled data from three randomized trials. Arch Intern Med157:1237, 1992
41.
EuropeanAtrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet342:1255, 1993
42.
Kottkamp H. , Hindricks G., Breithardt G.Role of anticoagulant therapy in atrial fibrillation . J Cardiovasc Electrophysiol9:S86, 1998
43.
Hohnloser SH , Kuck KHAtrial fibrillation—maintaining sinus rhythm versus ventricular rate control: The PIAF trial. J Cardiovasc Electophysiol9:S121, 1998
44.
The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators.Atrial fibrillation follow-up investigation of rhythm management—the AFFIRM study design. Am J Cardiol79:1198, 1997
45.
Middlekauff HR, Stevenson WG, Stevenson LWPrognostic significance of atrial fibrillation in advanced heart failure: A study of 390 patients. Circulation84:40, 1991
46.
Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials . Circulation82:1106, 1990
47.
Cox JL, Schuessler RB, Lappas DG, et al. An 8 ½-year clinical experience with surgery for atrial fibrillation . Ann Surg224:267, 1996
48.
Jordaens L., Lau CP, Timmermans C., et al. Initial clinical experience with the Metrix automatic implantable atrial defibrillator. Circulation96:I-208, 1997
49.
Santini M., Pandozi C., Gentilucci G., et al. Intra-atrial defibrillation of human atrial fibrillation. J Cardiovasc Electrophysiol9:S 170, 1998
50.
Saksena S., Delfaut P., Prakash A., et al. Multisite electrode pacing for prevention of atrial fibrillation . J Cardiovasc Electrophysiol9:S155, 1998
